Bone Biologics Corp (BBLG) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bone Biologics Corporation, a Delaware corporation, with a reporting date of April 7, 2025. The Company is incorporated in Delaware and maintains its principal executive offices in Burlington, MA. Its common stock (BBLG) and warrants (BBLGW) are listed on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory listing event rather than financial performance data.
Material Changes
On April 7, 2025, the Company received a notification from the Listing Qualifications Staff of The Nasdaq Stock Market LLC indicating non-compliance with Nasdaq Listing Rule 5550(a)(2). The Company's common stock failed to maintain a minimum closing bid price of $1.00 per share for the last 30 consecutive business days. This notification has no immediate effect on the listing status but initiates a compliance period.
Outlook, Management Commentary, and Risks
- Compliance Period: The Company has been granted an 180-calendar day compliance period, ending October 6, 2025, to regain compliance.
- Regaining Compliance: To regain compliance, the Company must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within the compliance period.
- Management Action Plan: The Company intends to seek stockholder approval for a reverse stock split at its upcoming annual meeting. If approved and the stock price remains below $1.00, the Board may authorize the split to increase the per-share price.
- Delisting Risk: If the Company fails to regain compliance, Nasdaq will provide notice of delisting. The Company retains the right to appeal such a determination to a Nasdaq hearings panel.
- Forward-Looking Statements: The filing includes standard disclaimers regarding uncertainties, including the ability to regain compliance and maintain listing status.
Investor Verification Checklist
- Verify the current closing bid price of BBLG to assess proximity to the $1.00 threshold.
- Confirm the date of the upcoming annual meeting of stockholders where the reverse stock split will be proposed.
- Review the Company's most recent Form 10-K for detailed risk factors and financial liquidity status.
- Monitor future 8-K filings for the outcome of the stockholder vote on the reverse stock split.
- Check for any subsequent correspondence from Nasdaq regarding the status of the compliance period.